David Patenaude
Foot & Ankle Surgery · Saint Cloud, MNNPI 1558348557
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (47.6%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 22 manufacturers reported payments, led by Arthrex at 36.7% of the total.
Across 71 payments — averaging $92.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$2K
- Gemini Medical LLC$1K
- Foundation Medical, LLC$1K
- Stryker$769
- Reprise Biomedical, Inc.$181
- Bone Support Inc.$79
- plus $603 from 16 others
What the payments were for
- Travel & lodging$1,32420%
- Food & beverage$2,11732%
- Education$3,12148%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 5 | $2,411 |
| Gemini Medical LLC | 3 | $1,279 |
| Foundation Medical, LLC | 12 | $1,240 |
| Stryker | 15 | $769 |
| Reprise Biomedical, Inc. | 7 | $181 |
| Bone Support Inc. | 1 | $79 |
| Orthofix Medical, Inc. | 4 | $76 |
| Next Science LLC | 2 | $70 |
| Paragon 28, Inc. | 3 | $65 |
| Smith+Nephew | 3 | $50 |
| Linvatec Corporation | 1 | $49 |
| Organogenesis Inc. | 2 | $40 |
| Medtronic | 2 | $38 |
| Integra Lifesciences Corporation | 2 | $36 |
| Nevro Corp. | 1 | $30 |
| Medshape, Inc. | 1 | $29 |
| Merck | 2 | $27 |
| Boston Scientific | 1 | $23 |
| Bioventus LLC | 1 | $23 |
| Paratek Pharmaceuticals, Inc. | 1 | $18 |
| Vertex | 1 | $15 |
| Kerecis Limited | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INBONE$430
How this compares
$6,562 in reported general payments places this provider in the 70th percentile of 102 foot & ankle surgery providers in Minnesota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Econazole Nitrate | 22 | $790 |
| Ketoconazole | 14 | $670 |
| Fluconazole | 13 | $232 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 37 | $191 |
| Cephalexin | 28 | $133 |
| Doxycycline Hyclate | 13 | $76 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Saint Cloud
- Gregory RouwSaint Cloud$9K
- Karenthea RouwSaint Cloud$6K
- Ashton NelsenSaint Cloud$3K
- Johannes CoetzeeEdina$4.7M
- Troy BoffeliSaint Paul$1.7M
- Jeffrey SeyboldEdina$270K
- Kyle AbbenSt Louis Park$130K
- Collin MesserlySaint Paul$50K
- Ryan ReinkingDuluth$48K
- Kevin MahoneyMarshall$39K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.